Our institute focuses on the discovery, development, and clinical translation of stem cell–based therapies. By integrating laboratory science, clinical insight, and regulatory strategy, we aim to unlock the full potential of cellular medicine for human health and longevity.
By combining cellular engineering, biomolecular profiling, and precision delivery systems, we design next-generation stem cell therapies tailored to individual patient biology. Our work supports healthy aging, tissue regeneration, and chronic disease management.
We focus primarily on mesenchymal stromal cells and other clinically relevant adult stem cell populations with strong regenerative and immunomodulatory potential.
All therapies are developed in alignment with applicable regulatory frameworks, and many are currently under clinical evaluation or approved for specific indications.
We apply strict manufacturing controls, batch testing, and long-term monitoring to maintain consistency, safety, and therapeutic integrity.
Stem cell approaches may benefit patients with degenerative conditions, inflammatory diseases, and age-related decline, depending on individual medical evaluation.
The Tasly Institute represents a new benchmark in regenerative medicine, combining scientific rigor with a long-term vision for human health.
Clinical Research Advisor
